Role of myeloid-derived suppressor cells in tumor recurrence
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10555-023-10079-1.pdf
Reference341 articles.
1. Coleman, C. (2017). Early detection and screening for breast cancer. Seminars in Oncology Nursing, 33, 141–155.
2. Tsodikov, A., et al. (2017). Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials. Annals of Internal Medicine, 167, 449–455.
3. Bivona, T. G., & Doebele, R. C. (2016). A framework for understanding and targeting residual disease in oncogene-driven solid cancers. Nature Medicine, 22, 472–478.
4. Dasari, A., Grothey, A., & Kopetz, S. (2018). Circulating tumor DNA-defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies. Journal Clinical Oncology, 36(35), 3437.
5. Sosa, M. S., Avivar-Valderas, A., Bragado, P., Wen, H. C., & Aguirre-Ghiso, J. A. (2011). ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: Opportunities to control dormant residual disease. Clinical Cancer Research, 17, 5850–5857.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation;Cell Death & Disease;2024-07-16
2. Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy;Discover Oncology;2024-05-25
3. Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells;International Journal of Molecular Sciences;2024-04-29
4. PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI‐based approach for future drug repurposing exploration;Interdisciplinary Medicine;2024-03-16
5. Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung disease;International Immunopharmacology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3